Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-01-23
2007-01-23
Hayes, Robert C. (Department: 1649)
Chemistry: molecular biology and microbiology
Vector, per se
C536S023510
Reexamination Certificate
active
10262141
ABSTRACT:
Inadequate growth due to deficiencies in growth hormone (GR), growth hormone releasing hormone (GHRH), or genetic diseases can be ameliorated utilizing recombinant protein therapy with a novel GHRH analog having a sequence (SEQ ID NO:1). Also included is (1) a method of treating growth hormone-related deficiencies associated with the growth hormone pathway; (2) a method for treating growth hormone-related deficiencies associated with genetic disease; (3) a method to improve growth performance in an animal; (4) a method of treating an animal having a growth deficiency disease; (5) a method of increasing the efficiency of an animal used for food; and (6) a method to enhance growth in an animal.
REFERENCES:
patent: 4410512 (1983-10-01), Bowers
patent: 4839344 (1989-06-01), Bowers et al.
patent: 5023322 (1991-06-01), Kovacs et al.
patent: 5036045 (1991-07-01), Thorner
patent: RE33699 (1991-09-01), Drengler
patent: 5084442 (1992-01-01), Felix et al.
patent: 5137872 (1992-08-01), Seely et al.
patent: 5298422 (1994-03-01), Schwartz et al.
patent: 5374544 (1994-12-01), Schwartz et al.
patent: 5486505 (1996-01-01), Bowers et al.
patent: 5696089 (1997-12-01), Felix et al.
patent: 5756264 (1998-05-01), Schwartz et al.
patent: 5776901 (1998-07-01), Bowers et al.
patent: 5792747 (1998-08-01), Schally et al.
patent: 5846936 (1998-12-01), Felix et al.
patent: 5847066 (1998-12-01), Coy et al.
patent: 5854211 (1998-12-01), Johansen et al.
patent: 6110932 (2000-08-01), Carpino et al.
patent: 6123964 (2000-09-01), Asgharnejad et al.
patent: 6127341 (2000-10-01), Hansen et al.
patent: WO 92/00095 (1992-01-01), None
patent: WO 99/05300 (1999-02-01), None
Campbell, Robert M., et al., “Rational Design, Synthesis, and Biological Evaluation of Novel Growth Hormone Releasing Factor Analogues”. Biopolymers (Peptide Science), 1995, vol. 37, pp. 67-88.
Draghia-Akli, Ruxandra. et al., “Myogenic Expression of an Injectable Protease-Resistant Growth Hormone-Releasing Hormone Augments Long-Term Growth in Pigs”. Nature Biotechnology, Dec. 1999, vol. 17, pp. 1179-1183.
Pomes A., et al.,Solubilization&characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes, Biochemical & Biophysical Research Communications, Article 1275, 1996, pp. 939-945, vol. 225.
Pong, S-S., et al.,Identification of a new g-protein-linked receptor for growth hormone secretagogues, Molecular Endocrinology, 1996, pp. 57-61, The Endocrine Society.
Anderson, et al., Human Gene Therapy, Nature, vol. 392, Supplement, Apr. 30, 1998.
Verma, et al., Gene Therapy—Promises, Problems and Prospects, Nature, vol. 389, pp. 239-242, Sep. 18, 1997.
Scanlon MF et al.,Regulation of Growth Hormone Secretion, Hormone Research 1996, pp. 149-154, vol. 46, S. Karger AG Basel.
Skuse D et al.,Quality of life in Turner syndrome is related to chromosomal constitution: implications for genetic counselling and management, Acta Paediatr Suppl 1999, pp. 110-113, vol. 428, Scandinavian Univ. Press.
D'Costa AP et al.,The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J. Reprod. Fert. Suppl. 1993, pp. 87-98, vol. 46, Journals of Reproduction & Fertility Ltd., Great Britain.
Bercu BB et al.,Growth hormone secretagogues in children with altered growth, Acta Paediatr Suppl 1997, pp. 102-106, vol. 423, Scandinavian Univ. Press.
Gesundheit N et al.,Endocrine Therapy with Recombitant Hormones and Growth Factors, Molecular Endocrinology: Basic Concepts & Clinical Correlations, 1995, Ch. 30, pp. 491-507, Raven Press, Ltd., New York.
Erling A,Methodological considerations in the assessment of health-related quality of life in children, Acta Paediatr Suppl 1999, pp. 106-107, vol. 428, Scandinavian Univ. Press.
Savage MO et al.,Growth in Crohn's disease, Acta Paediatr Suppl 1999, pp. 89-92, vol. 428, Scandinavian Univ. Press.
Parks JS et al.,Growth Hormone Deficiency, Molecular Endocrinology Basic Concepts & Clinical Correlations 1995, Ch. 29, pp. 473-490, Raven Press, Ltd., New York.
Thorner MO et al.,Extrahypothalamic Browth-Hormone-Releasing Factor(GRF)Secretion Is a Rare Cause of Acromegaly: Plasma GRF Levels in 177 Acromegalic Patients, Journal of Clinical Endocrinology & Metabolism 1984, pp. 846-849, vol. 59, No. 5, The Endocrine Society, USA.
Corpas E et al.,Continuous Subcutaneous Infusions of Growth Hormone(GH)Releasing Hormone 1-44 for 14 Days Increase GH and Insulin-Like Growth Factor-1 Levels in Old Men; Journal of Clinical Endocrinology & Metabolism, 1993, pp. 134-138, vol. 76, No. 1, The Endocrine Society, USA.
Esch FS et al.,Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity, Biochemical & Biophysical Research Communications, Nov. 16, 1982, pp. 152-158, vol. 109, No. 1, Academic Press.
Frohman LA et al.,Metabolic Clearance & Plasma Disappearance Rates of Human Pancreatic Tumor Growth Hormone Releasing Factor in Man, J. Clin. Invest., May 1984, pp. 1304-1311, vol. 73, The American Society for Clinical Investigation, Inc.
Corpas E et al.,Human growth hormone&human aging, Endocrine Reviews, 1993, pp. 20-39, vol. 14, No. 1, The Endocrine Society, USA.
Campbell RM et al.,GRF analogs&fragments: correlation between receptor binding, activity&structure, Peptides, 1991, pp. 569-574, vol. 12, Pergamon Press plc, USA.
Martin RA et al.,Dipeptidyl peptidase IV(DPP-IV)from pig kidney cleaves analogs of bovine growth hormone-releasing factor(bGRF)modified at position 2 with Ser, Thr or Val. extended DPP-IV substrate specificity?, Biochimica et Bioshysica Acta, 1993, pp. 252-260, vol. 1164, Elsevier Science Publishers BV.
Su C-M et al.,In vitro stability of growth hormone releasing factor(GRF)analogs in porcine plasma, Horm.metab.Res, 1991, pp. 15-21, vol. 23, Georg Thieme Verlag Stuttgart NY.
Kubiak TM et al.,In vitro metabolic degradation of a bovine growth hormone-releasing factor analog LEU27-bGRF(1-29)NH2in bovine&porcine plasma, Drug Metabolism & Disposition 1989, pp. 393-397, vol. 17, No. 4, The American Society for Pharmacology & Experimental Therapeutics, USA.
Frohman MA et al.,Cloning&characterization of mouse growth hormone-releasing hormone(GRH)complementary DNA: increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse, Molecular Endocrinology, 1989, pp. 1529-1536, 0888-8809/89, The Endocrine Society.
Aihara H et al.,Gene transfer into muscle by electroporation in vivo, Nature Biotechnology, Sept. 1998, pp. 867-869, vol. 16.
Li X et al.,Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences, Nature Biotechnology, Mar. 1999, pp. 241-245, vol. 17.
Draghia-Akli R et al.,Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector, Nature Biotechnology, Nov. 1997, pp. 1285-1289, vol. 15.
Tanner JW et al.,Modulation of growth hormone(GH)secretion and GH mRNA levels by GH-releasing factor, somatostatin and secretagogues in cultured bovine adenohypophysial cells, Journal of Endocrinology, 1990, pp. 109-115, vol. 125, Journal of Endocrinology Ltd., Great Britain.
Coleman ME,Myogenic vector expression of insulin-like growth factor 1 stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice, The Journal of Biological Chemistry, May 19, 1995, pp. 12109-12116, vol. 270, No. 20, The American Society for Biochemistry & Molecular Biology, Inc.
Draghia-Alki Ruxandra
Schwartz Robert J.
Baylor College of Medicine
Hayes Robert C.
Jackson Walker L.L.P.
LandOfFree
Polynucleotides encoding a super-active porcine growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotides encoding a super-active porcine growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides encoding a super-active porcine growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3782000